You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 8, February 28, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Prognosis/ Outcomes
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Presenting Plasma HIV RNA Level and Rate of CD4 T-Cell Decline

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The study by Dr Rodriguez and colleagues1 concludes that presenting human immunodeficiency virus (HIV) plasma RNA viral load only minimally predicts the rate of CD4 cell decline in individuals with HIV infection and hypothesizes that a significant (>90%) amount of HIV disease progression and pathogenesis is due to factors other than viral load. This is further discussed in the accompanying editorial by Drs Henry, Tebas, and Lane.2 The results are portrayed as casting doubt on the utility of an early viral load measurement to predict disease outcome in individuals. However, these results actually highlight the interindividual variability of the association between 2 surrogate markers. With further investigation, the results may indeed impugn the reliability of early CD4 T-cell loss trajectory estimates, but this study does not address either (1) the reliability of RNA viral load measurements for predicting the critical outcome of the development of clinical AIDS . . . [Full Text of this Article]

Geoffrey S. Gottlieb, MD, PhD
gottlieb@u.washington.edu

Stephen E. Hawes, PhD; David C. Nickle, MS; Joshua T. Herbeck, PhD; Nancy B. Kiviat, MD; James I. Mullins, PhD
University of Washington
Seattle

Papa Salif Sow, MD
Université Cheikh Anta Diop de Dakar
Senegal, West Africa



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTERS

Presenting Plasma HIV RNA Level and Rate of CD4 T-Cell Decline
Viviane D. Lima, Robert S. Hogg, and Julio S. G. Montaner
JAMA. 2007;297(8):805-806.
EXTRACT | FULL TEXT  

Presenting Plasma HIV RNA Level and Rate of CD4 T-Cell Decline—Reply
Benigno Rodriguez, Michael M. Lederman, Ajay K. Sethi, Vinay K. Cheruvu, Ronald J. Bosch, Jeffrey Martin, and Steven Deeks
JAMA. 2007;297(8):806-807.
EXTRACT | FULL TEXT  

Presenting Plasma HIV RNA Level and Rate of CD4 T-Cell Decline—Reply
W. Keith Henry and Pablo Tebas
JAMA. 2007;297(8):807.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Predictive Value of Plasma HIV RNA Level on Rate of CD4 T-Cell Decline in Untreated HIV Infection
Benigno Rodríguez, Ajay K. Sethi, Vinay K. Cheruvu, Wilma Mackay, Ronald J. Bosch, Mari Kitahata, Stephen L. Boswell, W. Christopher Mathews, David R. Bangsberg, Jeffrey Martin, Christopher C. Whalen, Scott Sieg, Suhrida Yadavalli, Steven G. Deeks, and Michael M. Lederman
JAMA. 2006;296(12):1498-1506.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.